Evidence map›Paper›PMID 33936027›Full record

ArticleFrontiers in immunology2021

Case Report: Expanding Clinical, Immunological and Genetic Findings in Sideroblastic Anemia With Immunodeficiency, Fevers and Development Delay (SIFD) Syndrome.

Leonardo Oliveira Mendonca, Alex Isidoro Prado, Izelda Maria Carvalho Costa, Marcia Bandeira, Rafael Dyer, Samar Freschi Barros, Karen Francine Khöler, Luiz Augusto Marcondes Fonseca, Jorge Kalil, Fabio Morato Castro and 1 more

Abstract readCase Reports
In one paragraph

Article in Frontiers in immunology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Leonardo Oliveira MendoncaClinical Immunology and Allergy, School of Medicine, University of São Paulo, São Paulo, Brazil.
Alex Isidoro PradoClinical Immunology and Allergy, School of Medicine, University of São Paulo, São Paulo, Brazil.
Izelda Maria Carvalho CostaDiscipline of Dermatology, University of Brasília, Brasília, Brazil.
Marcia BandeiraDepartment of Pediatric Rheumatology, Hospital Pequeno Príncipe, Paraná, Brazil.
Rafael DyerDepartment of Surgical Pathology, School of Medicine, University of São Paulo, São Paulo, Brazil.
Samar Freschi BarrosLaboratory for Immunological Investigation (LIM-19), Heart Institute, University of São Paulo, São Paulo, Brazil.
Karen Francine KhölerLaboratory for Immunological Investigation (LIM-19), Heart Institute, University of São Paulo, São Paulo, Brazil.
Luiz Augusto Marcondes FonsecaClinical Immunology and Allergy, School of Medicine, University of São Paulo, São Paulo, Brazil.
Jorge KalilClinical Immunology and Allergy, School of Medicine, University of São Paulo, São Paulo, Brazil.
Fabio Morato CastroClinical Immunology and Allergy, School of Medicine, University of São Paulo, São Paulo, Brazil.
Myrthes Anna Maragna Toledo-BarrosClinical Immunology and Allergy, School of Medicine, University of São Paulo, São Paulo, Brazil.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Since the first description of the syndrome of sideroblastic anemia with immunodeficiency, fevers and development delay (SIFD), clinical pictures lacking both neurological and hematological manifestations have been reported. Moreover, prominent skin involvement, such as with relapsing erythema nodosum, is not a common finding. Up to this moment, no genotype and phenotype correlation could be done, but mild phenotypes seem to be located in the N or C part. B-cell deficiency is a hallmark of SIFD syndrome, and multiple others immunological defects have been reported, but not high levels of double negative T cells. Here we report a Brazilian patient with a novel phenotype of SFID syndrome, carrying multiple immune defects and harboring a novel mutation on TRNT1 gene.

Indexed as

Disease SusceptibilityFeverPhenotypeAllelesAnemia, SideroblasticBiopsyDevelopmental DisabilitiesDNA Mutational AnalysisFemaleGenetic Association StudiesGenetic Predisposition to DiseaseGenotypeHumansImmunologic Deficiency SyndromesLymphocytesMutationB-cell deficiencyerythema nodosumrecurrent feverSIFDTRNT1

Identifiers

PMID33936027
PMCPMC8079983

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.